CMR Features in Patients With Suspected Myocarditis
Completed
Conditions studied: Outcome, Fatal
In brief
Presentation of myocarditis is heterogeneous, often ranges from being asymptomatic, to chest pain, dyspnoea, palpitations, and even sudden cardiac death. Diagnosing myocarditis is challenging with no current uniform clinical gold-standard. CMR is a key investigative tool, however the predictive value of CMR features is unknown. In this study we assess 670 consecutive patients with suspected myocarditis who were referred for CMR between 2002 and 2015 at the BWH. CMR features such as late gadolinium sizing, T1 mapping, extracellular volume fraction assessment, strain analysis (feature tracking), clinical data, labortory tetsings and electrocardiogramm are linked to the outcome in order to assess its predictive value.
Key facts
- Study ID
- NCT03470571
- Run by
- Brigham and Women's Hospital
- People needed
- 670
- Starts
- 2016-06-01
- Expected to finish
- 2018-02-01
- Last updated by the study team
- 2018-03-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- patients referred by their treating physician to undergo CMR for "suspected myocarditis" as the primary clinical question
You may not qualify if…
- evidence of coronary artery disease
- hypertrophic cardiomyopathy
- arrhythmogenic right ventricular cardiomyopathy
- cardiac sarcoidosis
- cardiac amyloidosis
- takotsubo cardiomyopathy
- constrictive pericarditis
- Loeffler endocarditis
- ventricular non-compaction
- cardiac tumor
- pulmonary embolism
- severe valve disease
Where it is running
- Brigham and Women's Hospital, Shapiro Cardiovascular Center — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.